Regulatory & Legal

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

With its first patient enrolled and key EU approvals, Inhibikase pushes its PAH drug IKT-001 forward, balancing clinical hope with financial realities.

After two rejections and a dramatic financial restructuring, Atara Biotherapeutics has a clear path to resubmit its key cancer therapy to the FDA.

Resideo posted strong Q1 results with an 8% revenue jump to $1.91B, setting a positive stage for the planned separation of its ADI distribution arm.

From over 134,000 applicants, ten nurses are finalists for a $250K prize, shining a light on their work and the challenges facing the global nursing profession.

A new AI-driven ecosystem promises to cut GMP media manufacturing to just 4 weeks, aiming to break a critical bottleneck in cell and gene therapy development.

Groundbreaking research suggests routine X-rays are crucial for young ACL patients to prevent growth issues and reinjury, potentially changing care standards.

Baltimore's Coppin State University reports a historic 23,000 applications, a massive surge that bucks national trends of declining college enrollment.

A new nonstop route from Austin to the Cayman Islands kicks off with a weekly ticket giveaway, sparking a digital gold rush for Central Texas travelers.

A new strategic alliance brings European cGMP-grade vitamin APIs to the U.S., promising to enhance quality and supply reliability for compounding pharmacies.

Greystar's new 402-unit community opens, blending modern amenities with nature access amid Charlotte's rapidly evolving and competitive rental market.

Daimler-backed Torc Robotics hires ex-Alphabet exec Tobias Wessels, signaling a major push to get its Level 4 autonomous trucks on the road by 2027.

From nano-surfactants to pharmaceuticals, SureNano Science is betting its future on a novel obesity drug. Can this microcap survive the big leagues?

America's only beekeeper-owned co-op partners with a top PR firm to meet consumer demand for authenticity and amplify its century-old American legacy.

A new report from The Humane League reveals which foodservice providers are leading the cage-free egg transition and which are failing to report progress.

Pharma and COVID-response leader John Young joins UCSF's QBI to translate its cutting-edge protein science into transformative therapies and partnerships.

Facing delisting, Solana infrastructure firm Solmate executes a reverse split. Is it a strategic reset for its UAE ambitions or a sign of deeper trouble?

Impulse Biomedical, a Cape Town startup, enters the US market via a Maryland program, bringing a reloadable epi-pen and an ergonomic inhaler sleeve.

A new report reveals that equipment fires, regulatory hurdles, and subtle operational flaws are emerging as major threats to the clean energy transition.

Amid a surging lithium market, Lithium Argentina posts stellar Q1 results, using its operational prowess to fund ambitious expansion projects in Argentina.